Trials / Completed
CompletedNCT04457063
Endothelial Cell Loss After Penetrating Keratoplasty
Endothelial Cell Loss Following Toric ICL Implantation for Correction of Myopia and Astigmatism After Penetrating Keratoplasty
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Alexandria University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This work aimed at the assessment of corneal endothelial cell loss after toric ICL implantation for correction of myopia and astigmatism after penetrating keratoplasty.
Detailed description
Penetrating keratoplasty (PKP) is considered a safe and effective procedure.This work aimed at the assessment of corneal endothelial cell loss after toric ICL implantation for correction of myopia and astigmatism after penetrating keratoplasty.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | PKP | 1. The horizontal axis was marked with a pointed marker at the slit lamp immediately before surgery. 2. TICL loading into the STAAR injector cartridge 3. Temporal clear corneal 3 mm incision \& 2-side ports then viscoelastic injection into the AC 4. Implantation of the TICL using the injector, then rotation according to the implantation diagram guided with Mendez protractor, and lastly placement of the haptics under the iris. 5. Pupil constriction with A.Ch. 6. Washing the viscoelastic \&Wound hydration. 7. Topical antibiotic steroids (Vigamox and Tobradex) 4 times /day for 3weeks |
Timeline
- Start date
- 2018-07-01
- Primary completion
- 2020-06-01
- Completion
- 2020-06-15
- First posted
- 2020-07-07
- Last updated
- 2020-07-07
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04457063. Inclusion in this directory is not an endorsement.